🧥Daily prize draw•Win a Constructive Bio branded Patagonia jacket•Sign up to enter →🧥Daily prize draw•Win a Constructive Bio branded Patagonia jacket•Sign up to enter →🧥Daily prize draw•Win a Constructive Bio branded Patagonia jacket•Sign up to enter →🧥Daily prize draw•Win a Constructive Bio branded Patagonia jacket•Sign up to enter →🧥Daily prize draw•Win a Constructive Bio branded Patagonia jacket•Sign up to enter →🧥Daily prize draw•Win a Constructive Bio branded Patagonia jacket•Sign up to enter →

🧥Daily prize draw•Win a Constructive Bio branded Patagonia jacket•Sign up to enter →🧥Daily prize draw•Win a Constructive Bio branded Patagonia jacket•Sign up to enter →🧥Daily prize draw•Win a Constructive Bio branded Patagonia jacket•Sign up to enter →🧥Daily prize draw•Win a Constructive Bio branded Patagonia jacket•Sign up to enter →🧥Daily prize draw•Win a Constructive Bio branded Patagonia jacket•Sign up to enter →🧥Daily prize draw•Win a Constructive Bio branded Patagonia jacket•Sign up to enter →

SynBioBeta

SynBioBeta 2026

Rewriting biology
to create better therapeutics

Constructive Bio uses an expanded genetic code to manufacture peptide and protein therapeutics with non-canonical amino acids, unlocking properties that natural biology cannot achieve.

Constructive Bio Technology

57+

ncAAs in our library

Syn61

Recoded E. coli chassis

$58M

Series A funding

Cambridge, UK

Headquarters

This is a mini-site for SynBioBeta 2026. Visit constructive.bio for full details on our platform, pipeline, and publications.